Express News | Available Nationwide: Juvéderm® Voluma® Xc for Moderate to Severe Temple Hollowing
Available Nationwide: JUVÉDERM VOLUMA XC for Moderate to Severe Temple Hollowing
European Medicines Agency Revokes AbbVie's Hepatitis Drug Approval
AbbVie Withdraws Exviera From EU Market for Commercial Reasons
Express News | EMA: Abbvie Deutschland Gmbh & Co. Kg, Notified Commission of Decision to Discontinue Marketing of Exviera for Commercial Reasons
Express News | EMA: On 25 Sept European Commission Withdrew Marketing Authorisation for Exviera (Dasabuvir) in EU
AbbVie to Host Third-Quarter 2024 Earnings Conference Call
AbbVie Inc. (ABBV) Projects Mid-Single-Digit Sales Growth Over Next 3 Years
AbbVie Seeks Approval for Lung Cancer Candidate Teliso-V
Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It?
Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent Set to Advance in Top Drug Sales
Is AbbVie Inc.'s (NYSE:ABBV) ROE Of 78% Impressive?
Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
(ABBV) - Analyzing AbbVie's Short Interest
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Leerink Partners Maintains AbbVie(ABBV.US) With Hold Rating
AbbVie's Parkinson's Drug Tavapadon: A Market Perform Rating Amidst Competitive Landscape and Clinical Trials
CNBC Halftime Report Final Trades: Meta Platforms, Accenture, AbbVie, The Walt Disney Company
AbbVie Submits BLA for Teliso-V in NSCLC With C-Met Protein Overexpression